INTRODUCTION
Povidone, also known as PVP (polyvinylpyrrolidone), is a polymer derived from the polymerization of 1-vinyl-2-pyrrolidone (C₆H₉NO). As a non-ionic polymer, it is widely used in pharmaceutical manufacturing.
Povidone exists in various grades with different molecular weights and viscosities, which are characterized by the K-value:
Grade | K-value | Molecular weight |
Povidone K12 | 10.2 – 13.8 | 3,000 – 7,000 |
Povidone K15 | 12.75 – 17.25 | 8,000 – 12,000 |
Povidone K17 | 15.3 – 18.36 | 10,000 – 16,000 |
Povidone K25 | 22.5 – 27 | 30,000 – 40,000 |
Povidone K30 | 27 – 32.4 | 45,000 – 58,000 |
Povidone K60 | 54 – 64.8 | 270,000 – 400,000 |
Povidone K90 | 81 – 97.2 | 1,000,000 – 1,500,000 |
Povidone VA64 | Also known as Copovidone, a copolymer of 1-vinyl-2-pyrrolidone (C₆H₉NO) and vinyl acetate (C₄H₆O₂) |
Povidone I | Complex of Polyvinylpyrrolidone (PVP) and Iodine |
APPLICATION
Applications of Povidone in Pharmaceutical Formulation:
Tablets:
- Acts as a binder in tablet formulations, with various Povidone grades suitable for different manufacturing processes such as wet granulation, direct compression, or dry granulation.
- Provides effective binding for high-drug-load formulations, improving compressibility of the powder blend.
- Balances binding strength, tablet hardness, and disintegration, ensuring tablets have high mechanical strength and low friability while maintaining optimal disintegration and drug dissolution.
Film-Coated Tablets: Used as a component in film-coating solutions, reducing the viscosity of HPMC-based coatings without compromising film formation and moisture protection.
Solid Dispersions: Enhances solubility and reduces recrystallization of poorly soluble drugs in solid dispersions.
Extended-Release Tablets: Functions as a matrix-forming agent, modulating drug release in extended-release formulations.
Topical and Liquid Formulations (Suspensions, Syrups, Eye Drops, Nasal Sprays, Injections):
- Improves solubility of poorly soluble active ingredients.
- Acts as a thickening and suspending agent in liquid and topical formulations.
- Masks the bitter taste of certain drugs in oral liquid formulations by forming non-bitter complexes.
- Prevents drug recrystallization, ensuring stability in liquid formulations and softgel suspensions.
COMMON GRADES OF POVIDONE
Povidone K25/K30:
- Most widely used binder in pharmaceutical formulations.
- Suitable for wet granulation and direct compression processes.
- Used as a film-coating ingredient in tablet coatings.
- Forms taste-masking complexes with drugs like Paracetamol, Guaifenesin.
- Enhances drug solubility in solid dispersions.
Povidone K90:
- Functions as a matrix-forming agent for extended-release formulations.
- Effective binder for poorly compressible powders and high-drug-load formulations.
Povidone K17:
- Produces low-viscosity solutions, reducing discomfort in ophthalmic and nasal formulations.
- Low molecular weight minimizes residual accumulation in the body, making it safer for injectable formulations.
Povidone VA64 (Copovidone): Binder for dry granulation processes, especially suitable for moisture-sensitive drugs.
Beyond its primary role as a binder, Povidone serves various functions across multiple dosage forms. The selection of the appropriate Povidone grade and concentration should consider viscosity, drug properties, manufacturing process, and final product requirements to achieve optimal formulation performance.
